FDA Import Refusal 300-1529453-1/11/1 — Baxter Corporation
The FDA refused shipment 300-1529453-1/11/1 from Baxter Corporation (Canada) on Feb 5, 2019. The refused product falls under Drugs and Biologics — CYCLOPHOSPHAMIDE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 5, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62IIA15 CYCLOPHOSPHAMIDE (ANTI-NEOPLASTIC)
- Charges
- 75